[Ventricular fibrillation at the acute phase of myocardial infarction: prognosis after resuscitation].
D000328:Adult; D000404:Ajmaline / Q000627:therapeutic use; D000787:Angina Pectoris / Q000150:complications; D002986:Clinical Trials as Topic; D003937:Diagnosis, Differential; D004554:Electric Countershock; D005260:Female; D006323:Heart Arrest / Q000209:etiology / Q000628:therapy; D006801:Humans; D007362:Intensive Care Units; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy / Q000209:etiology; D010138:Pacemaker, Artificial; D011379:Prognosis; D011433:Propranolol / Q000627:therapeutic use; D012151:Resuscitation; D014693:Ventricular Fibrillation / Q000209:etiology*
D000404:Ajmaline; D008012:Lidocaine; D011433:Propranolol
Fibrillation ventriculaire à la phase aiguë de l'infarctus du myocarde: pronostic après resuscitation.